IRX 616a World 1st Fast Acting Non Addictive Anxiety Solution, page-7

  1. 1,262 Posts.
    lightbulb Created with Sketch. 299
    Sorry people, I can answer my own question with the help of Google Gemini.

    ---
    Company Actions to Mitigate or Remove Risk:
    Addressing Non-Clinical Toxicity Studies: The primary action InhaleRx is taking is to complete the required non-clinical toxicology studies. The company expects to be able to lift the clinical hold upon completion of these studies, which will finalize the IRX-616a non-clinical testing program. This combined program is expected to be completed by the end of 2027.
    ---
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
4.1¢
Change
-0.001(2.38%)
Mkt cap ! $8.751M
Open High Low Value Volume
4.1¢ 4.1¢ 4.1¢ $7.526K 183.5K

Buyers (Bids)

No. Vol. Price($)
1 180072 3.5¢
 

Sellers (Offers)

Price($) Vol. No.
4.1¢ 15000 1
View Market Depth
Last trade - 10.55am 21/07/2025 (20 minute delay) ?
IRX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.